Literature DB >> 18847307

Recombinant human thyrotropin in the management of thyroid disorders.

Gilberto J Paz-Filho1, Hans Graf.   

Abstract

BACKGROUND: Recombinant human thyroid stimulating hormone (rhTSH) is a valuable tool in the management of thyroid diseases. It is useful for radioiodine ablation in patients with differentiated thyroid carcinoma (DTC), for their follow-up, and for treatment of selected patients with metastatic or recurrent DTC. More recently, it has been suggested that rhTSH is useful for treatment of multinodular goiter and amiodarone-induced thyrotoxicosis, as well as for diagnosis of congenital hypothyroidism.
OBJECTIVE: To provide an outline of literature regarding the uses of rhTSH in thyroid diseases.
METHODS: We performed a literature search for relevant articles in the PubMed database.
CONCLUSION: rhTSH has important roles in management of thyroid diseases, and some are still controversial. For patients with DTC, it avoids the need for thyroid hormone withdrawal, without being detrimental to short-term outcomes. Further studies are warranted to assess its effects on long-term outcomes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18847307     DOI: 10.1517/14712598.8.11.1721

Source DB:  PubMed          Journal:  Expert Opin Biol Ther        ISSN: 1471-2598            Impact factor:   4.388


  4 in total

Review 1.  Non-surgical approach to the benign nodular goiter: new opportunities by recombinant human TSH-stimulated 131I-therapy.

Authors:  Steen Joop Bonnema; Søren Fast; Laszlo Hegedüs
Journal:  Endocrine       Date:  2011-10-05       Impact factor: 3.633

2.  Inability of recombinant human thyrotropin to predict the evolution from subclinical hypothyroidism to overt disease. A pilot study.

Authors:  C Zafon; B Rodríguez; J B Montoro; D Cabo; J Mesa
Journal:  J Endocrinol Invest       Date:  2011-04-26       Impact factor: 4.256

Review 3.  Potential use of recombinant human thyrotropin in the treatment of distant metastases in patients with differentiated thyroid cancer.

Authors:  Joanna Klubo-Gwiezdzinska; Kenneth D Burman; Douglas Van Nostrand; Mihriye Mete; Jacqueline Jonklaas; Leonard Wartofsky
Journal:  Endocr Pract       Date:  2013 Jan-Feb       Impact factor: 3.443

4.  Capsaicin restores sodium iodine symporter-mediated radioiodine uptake through bypassing canonical TSH‒TSHR pathway in anaplastic thyroid carcinoma cells.

Authors:  Shichen Xu; Xian Cheng; Jing Wu; Yunping Wang; Xiaowen Wang; Liying Wu; Huixin Yu; Jiandong Bao; Li Zhang
Journal:  J Mol Cell Biol       Date:  2022-01-21       Impact factor: 6.216

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.